From Molecules to Medicines: Exploring Neurodegenerative Pathways for Targeted Neuropharmacology
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 127
Special Issue Editor
Interests: Parkinson’s disease; therapy; drug; repurposing; novel compound; neurodegeneration; neuroinflammation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological diseases affect a significant portion of the global population, contributing to significant morbidity and mortality. This Special Issue aims to delve into the intricate landscape of neurodegenerative pathology, shedding light on key elements such as endothelial dysfunction, blood–brain barrier (BBB) damage, oxidative stress, inflammation, coagulation pathway dysfunction, and neuronal and glial degeneration. This focus extends to the multifaceted challenges of drug development in neuropharmacology, spanning effective blood–brain barrier penetration, optimization of drug delivery systems, and the revolutionary impact of biomarkers in personalized neuropharmacology. As we navigate the complexities of the human brain and its signaling pathways, the goal is to foster breakthroughs that modify disease progression, enhance long-term survival, and elevate the quality of life for individuals affected by neurological diseases. Researchers are invited to contribute original articles and reviews across diverse research areas, including disease modeling, drug studies, and therapeutic interventions, in order to collectively advance our understanding and pave the way for innovative pharmacological interventions in neuropharmacology.
Dr. Malgorzata Zaremba
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- disease modeling
- drug studies
- therapeutic interventions
- neuropharmacology
- innovative pharmacological interventions
